Koyfin Home > Directory > Health Care > Amicus Therapeutics > Price / Earnings (ltm)

Amicus Therapeutics Price / Earnings (ltm) Chart (FOLD)

Amicus Therapeutics annual/quarterly Price / Earnings (ltm) from 2019 to 2019. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
Other Valuation Metrics:
  • Amicus Therapeutics Market Cap for the quarter ending March 03, 2018 was $2,811m a 48.80% increase of 1,372m year over year
  • Amicus Therapeutics Price / Book for the quarter ending March 03, 2018 was 7.12 a 34.98% increase of 2.49 year over year
  • Amicus Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $2,617m a 49.70% increase of 1,301m year over year
View Chart On Koyfin